hVIVO (HVO:7.75p) has announced a significant contract cancellation alongside a postponement and a smaller study cancellation that has led to material earnings downgrades. The company is a specialist ...

Dan Jones and the IC team unpack results from a retailer, what investors can learn from 25 years of volatility, and the ...

Takeovers and mergers are a natural part of life on the market. It makes sense for companies to buy or merge with competitors ...

Arguably, one company that fits this description is speciality polymers manufacturer Victrex (VCT), which is the world’s ...

Sensibly, management has been carefully managing costs and is maintaining tight control over working capital. Net cash ...

Having recently appointed a new chief executive, Raffi Stepanian, the medical technology company is building real sales ...

In terms of the fiscal landscape, the Labour government announced (October 2024) an increase in the tax rate on North Sea oil ...

Led by a team who made their name at turnaround specialist Hilco, the group is acquiring undervalued SME businesses at favourable prices by providing an exit to their founders. Moreover, by focusing ...

Ultimately, a narrowing of the 70 per cent share price discount to NAV is dependent on an improvement in property investment ...

There is certainly scope for further cuts, but it is not a case of ‘what goes up must come down’. The Bank of England has ...

The US drugmaker has stolen a march on Novo Nordisk by bringing a viable oral weight-loss medicine, orforglipron, into successful phase 3 clinical trials. An oral version is the holy grail for drugs ...

We mentioned yesterday that the coming weeks would be challenging for traders, with the potential for tariff delays, new tariffs, and posts on TruthSocial all sending shares in both directions. Well, ...